GlaxoSmithKline plc (GSK)

GSK is one of the world’s leading research-based pharmaceutical and healthcare companies, developing and supplying medicines to improve patients’ quality of life. We make prescription medicines, over-the-counter medicines and oral care, and nutritional healthcare products. Our medicines treat six major disease areas – asthma, virus control, infections, mental health, diabetes and digestive conditions.  In addition, we are a leader in the important area of vaccines and are developing new treatments for cancer. GSK is the largest private sector funder of R&D in the UK.

We have a challenging and inspiring mission: to improve the quality of human life by enabling people to do more, feel better and live longer. This mission gives us the purpose to develop innovative medicines and products that help millions of people around the world.

We are one of the few pharmaceutical companies researching both medicines and vaccines for the World Health Organization’s three priority diseases; HIV/AIDS, tuberculosis and malaria, and we are proud to have developed some of the leading global medicines in these fields.

GSK is a global organisation with offices in over 100 countries and major research centres in the UK, USA, Belgium and China. Our shares are listed on the London and New York Stock Exchanges and our corporate head office is in Brentford, UK. We are one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market.

For further information please visit

GlaxoSmithKline UK Limited
980 Great West Road,
Middlesex, TW8 9GS

General Enquiries:
Tel: 0208 047 5000